3143511000001109: Carace 20 Plus tablets (Organon Pharma (UK) Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \UK product\Virtual medicinal product\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \UK product\Virtual therapeutic moiety\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \UK product\Virtual therapeutic moiety\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \UK product\Trade family\Carace Plus\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing angiotensin-converting enzyme inhibitor\Product containing lisinopril\Product containing lisinopril in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing angiotensin-converting enzyme inhibitor\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing angiotensin-converting enzyme inhibitor\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing angiotensin-converting enzyme inhibitor\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing peptide\Product containing lisinopril\Product containing lisinopril in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing peptide\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing peptide\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing peptide\Product containing lisinopril\Product containing hydrochlorothiazide and lisinopril\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Lisinopril + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and lisinopril\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing lisinopril in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet\Carace 20 Plus tablets (Organon Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
1736341000001110	Carace 20 Plus tablets (Organon Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1736351000001113	Carace 20 Plus tablets (Organon Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start